Crit Care Med:中国ICU患者败血症的流行病学特征

2019-12-05 xing.T MedSci原创

由此可见,败血症影响了五分之一的ICU患者,其90天死亡率为35.5%。该研究的发现表明败血症负担很大,鉴于高死亡率,需要将败血症作为提高中国医疗质量的靶标。另外,需要进一步的研究来描述ICU外败血症的流行病学特征。

近日,危重病医学领域权威杂志Critical Care Medicine上发表了一篇研究文章,研究人员进行了一项全国性横断面调查,以确定中国ICU败血症患者的流行病学特征。

这项横断面调查研究是在2015年12月1日至2016年1月31日期间中国大陆四十四家医院完成的,参与者为所有根据败血症1标准诊断为败血症的ICU患者。研究人员记录了人口统计学、生理学和微生物学数据,并进行了90天的随访或死亡(如果早于90天的话)。研究人员计算了败血症的发生频率和90天死亡率,并确定与国内生产总值的关系。多元Logistic回归分析用于确定败血症患者90天死亡率的危险因素。

该研究纳入了232名败血症患者,其中786名患者(33.9%)发生了医院获得性败血症。最常见的感染部位为肺(68.2%),其次是腹部(26.6%)和血液(7.8%)。ICU患者败血症发生频率为每100例ICU患者中有20.6例(95%CI为15.8-25.4),90天死亡率为35.5%。败血症、严重败血症和败血性休克的比例分别为3.10%、43.6%和53.3%,其90天死亡率分别为2.78%、17.69%和51.94%。老年人、低体重、序贯器官衰竭评估评分较高、全身炎症反应综合征标准数、合并心力衰竭、血液系统肿瘤、免疫抑制、乳酸水平升高、感染部位(肺炎和血流)与90天死亡率相关。

由此可见,败血症影响了五分之一的ICU患者,其90天死亡率为35.5%。该研究的发现表明败血症负担很大,鉴于高死亡率,需要将败血症作为提高中国医疗质量的靶标。另外,需要进一步的研究来描述ICU外败血症的流行病学特征。 

原始出处:

Xie, Jianfeng.et al.The Epidemiology of Sepsis in Chinese ICUs A National Cross-Sectional Survey.critical care medicine.2019.https://journals.lww.com/ccmjournal/Abstract/onlinefirst/The_Epidemiology_of_Sepsis_in_Chinese_ICUs__A.95774.aspx

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2033134, encodeId=9d8c20331344b, content=<a href='/topic/show?id=cebb653925a' target=_blank style='color:#2F92EE;'>#流行病学特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65392, encryptionId=cebb653925a, topicName=流行病学特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Thu May 07 17:09:00 CST 2020, time=2020-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411332, encodeId=e3ba141133275, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sat Dec 07 14:09:00 CST 2019, time=2019-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595380, encodeId=3a7315953801f, content=<a href='/topic/show?id=44b993e977' target=_blank style='color:#2F92EE;'>#ICU患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9379, encryptionId=44b993e977, topicName=ICU患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=003c18235152, createdName=piaojinhua, createdTime=Sat Dec 07 14:09:00 CST 2019, time=2019-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610164, encodeId=d1d7161016434, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Dec 07 14:09:00 CST 2019, time=2019-12-07, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2033134, encodeId=9d8c20331344b, content=<a href='/topic/show?id=cebb653925a' target=_blank style='color:#2F92EE;'>#流行病学特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65392, encryptionId=cebb653925a, topicName=流行病学特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Thu May 07 17:09:00 CST 2020, time=2020-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411332, encodeId=e3ba141133275, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sat Dec 07 14:09:00 CST 2019, time=2019-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595380, encodeId=3a7315953801f, content=<a href='/topic/show?id=44b993e977' target=_blank style='color:#2F92EE;'>#ICU患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9379, encryptionId=44b993e977, topicName=ICU患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=003c18235152, createdName=piaojinhua, createdTime=Sat Dec 07 14:09:00 CST 2019, time=2019-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610164, encodeId=d1d7161016434, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Dec 07 14:09:00 CST 2019, time=2019-12-07, status=1, ipAttribution=)]
    2019-12-07 xugumin
  3. [GetPortalCommentsPageByObjectIdResponse(id=2033134, encodeId=9d8c20331344b, content=<a href='/topic/show?id=cebb653925a' target=_blank style='color:#2F92EE;'>#流行病学特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65392, encryptionId=cebb653925a, topicName=流行病学特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Thu May 07 17:09:00 CST 2020, time=2020-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411332, encodeId=e3ba141133275, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sat Dec 07 14:09:00 CST 2019, time=2019-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595380, encodeId=3a7315953801f, content=<a href='/topic/show?id=44b993e977' target=_blank style='color:#2F92EE;'>#ICU患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9379, encryptionId=44b993e977, topicName=ICU患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=003c18235152, createdName=piaojinhua, createdTime=Sat Dec 07 14:09:00 CST 2019, time=2019-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610164, encodeId=d1d7161016434, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Dec 07 14:09:00 CST 2019, time=2019-12-07, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2033134, encodeId=9d8c20331344b, content=<a href='/topic/show?id=cebb653925a' target=_blank style='color:#2F92EE;'>#流行病学特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65392, encryptionId=cebb653925a, topicName=流行病学特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fca128, createdName=licz0423, createdTime=Thu May 07 17:09:00 CST 2020, time=2020-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411332, encodeId=e3ba141133275, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sat Dec 07 14:09:00 CST 2019, time=2019-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595380, encodeId=3a7315953801f, content=<a href='/topic/show?id=44b993e977' target=_blank style='color:#2F92EE;'>#ICU患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9379, encryptionId=44b993e977, topicName=ICU患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=003c18235152, createdName=piaojinhua, createdTime=Sat Dec 07 14:09:00 CST 2019, time=2019-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1610164, encodeId=d1d7161016434, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Dec 07 14:09:00 CST 2019, time=2019-12-07, status=1, ipAttribution=)]

相关资讯

JCEM:中国老年人血糖测量与死亡风险

由此可见,负荷后2h血糖较高的个体比正常血糖的个体死亡风险高43%。OGTT的使用不足会导致较高死亡风险的个体未被发现,并且早期干预的机会会大大减少。

Clinica Chimica Acta:中国急性冠状动脉综合征患者非高密度脂蛋白胆固醇的目标需要调整:CCC-ACS项目的研究结果

指南建议将非高密度脂蛋白胆固醇(non-HDL-C)作为共同主要目标,并将非HDL-C目标设置为比低密度脂蛋白胆固醇(LDL-C)目标高30 µmg / dl。但在中国患者中,这一价值在很大程度上是不确定的。

Heart:中国东北地区房颤的流行病学特征

由此可见,东北地区的AF负担巨大,OAC治疗的未充分使用和合并症未能有效控制可能会在未来几十年中加剧AF患者的心血管结局。对于东北地区急需AF及相关危险因素长期管理的策略。

乙肝疫苗技术转让中国30周年, 默沙东参与者追忆历史细节

在今天的中国,每个新生儿都会在出生后的24小时内接种首针乙肝疫苗。而在这背后不为人知的是一段中国公共卫生史上难忘历程。在第二届中国国际进口博览会期间,一场特殊的庆祝仪式在医疗器械及医药保健馆举行。11月7日下午,默沙东公司举办了乙肝疫苗技术转让中国30周年特别活动。默沙东全球高级副总裁、中国总裁罗万里(Joe Romanelli),原中国疾控中心副主任梁晓峰,以及30年前参与乙肝项目技术转让的

提前退休的好生活对大脑有害?

一项基于人群的大型研究表明,提前退休的人尤其是女性,其认知能力下降的风险显著增加。针对中国农村地区超过17 000人的全国性调查结果显示,与不参加该计划的人相比,参加提前退休养老金计划的人的认知和记忆力得分显著较低。

Eur J Heart Fail:中国心力衰竭和左心功能不全的患病率

由此可见,HF的患病率有所增加,并且LV功能障碍在中国非常普遍。但是,HF患者高血压治疗和控制水平仍然很低。